Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
467.90
+2.05 (0.44%)
Aug 12, 2025, 3:29 PM IST
Accolade Revenue
Indraprastha Medical Corporation had revenue of 3.65B INR in the quarter ending June 30, 2025, with 4.94% growth. This brings the company's revenue in the last twelve months to 13.74B, up 6.80% year-over-year. In the fiscal year ending March 31, 2025, Indraprastha Medical Corporation had annual revenue of 13.56B with 8.97% growth.
Revenue (ttm)
13.74B
Revenue Growth
+6.80%
P/S Ratio
3.11
Revenue / Employee
4.61M
Employees
2,977
Market Cap
42.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 13.56B | 1.12B | 8.97% |
Mar 31, 2024 | 12.45B | 1.46B | 13.29% |
Mar 31, 2023 | 10.99B | 2.11B | 23.70% |
Mar 31, 2022 | 8.88B | 2.75B | 44.80% |
Mar 31, 2021 | 6.13B | -2.17B | -26.17% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 80.94B |
Aurobindo Pharma | 320.25B |